| AstraZeneca (AZN) |
GB |
$215.386B |
16.08 |
| Amgen (AMGN) |
US |
$160.365B |
14.37 |
| Gilead Sciences (GILD) |
US |
$139.009B |
14.44 |
| Vertex Pharmaceuticals (VRTX) |
US |
$118.029B |
0.00 |
| Bristol Myers Squibb (BMY) |
US |
$95.486B |
6.39 |
| GSK (GSK) |
GB |
$78.168B |
9.36 |
| CSL (CSLLY) |
AU |
$77.435B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
US |
$59.096B |
14.34 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$43.277B |
0.00 |
| Argenex SE (ARGX) |
NL |
$33.185B |
90.58 |
| BioNTech SE (BNTX) |
DE |
$26.443B |
0.00 |
| Royalty Pharma (RPRX) |
US |
$20.449B |
8.64 |
| Biogen (BIIB) |
US |
$19.469B |
8.40 |
| Insmed (INSM) |
US |
$18.554B |
0.00 |
| Illumina (ILMN) |
US |
$15.957B |
30.27 |
| Incyte (INCY) |
US |
$13.250B |
100.66 |
| Genmab (GNMSF) |
DK |
$13.116B |
13.41 |
| Genmab (GMAB) |
DK |
$13.017B |
14.60 |
| Exelixis (EXEL) |
US |
$12.585B |
21.37 |
| Moderna (MRNA) |
US |
$11.792B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
HK |
$11.368B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
US |
$11.027B |
17.91 |
| QIAGEN (QGEN) |
NL |
$10.746B |
20.91 |
| Ascendis Pharma (ASND) |
DK |
$10.648B |
0.00 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.413B |
26.59 |
| Exact Sciences (EXAS) |
US |
$10.066B |
0.00 |
| Bio-Techne Corp (TECH) |
US |
$8.331B |
31.08 |
| Blueprint Medicines (BPMC) |
US |
$8.289B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
GB |
$7.792B |
0.00 |
| Roivant Sciences (ROIV) |
GB |
$7.471B |
0.00 |
| Repligen (RGEN) |
US |
$7.162B |
80.17 |
| Revolution Medicines (RVMD) |
US |
$7.054B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
US |
$6.805B |
23.68 |
| Halozyme Therapeutics (HALO) |
US |
$6.654B |
12.74 |
| Jazz Pharmaceuticals (JAZZ) |
IE |
$6.623B |
6.50 |
| Legend Biotech (LEGN) |
US |
$6.549B |
0.00 |
| Guardant Health (GH) |
US |
$6.256B |
0.00 |
| TG Therapeutics (TGTX) |
US |
$5.829B |
153.00 |
| Nuvalent (NUVL) |
US |
$5.779B |
0.00 |
| Telix Pharmaceuticals (TLX) |
AU |
$5.438B |
0.00 |
| Anbio Biotechnology (NNNN) |
DE |
$5.323B |
0.00 |
| Axsome Therapeutics (AXSM) |
US |
$5.191B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.757B |
12.77 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$4.506B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$4.364B |
32.64 |
| Vaxcyte (PCVX) |
US |
$4.289B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
US |
$4.184B |
0.00 |
| Cytokinetics (CYTK) |
US |
$4.139B |
0.00 |
| Krystal Biotech (KRYS) |
US |
$4.135B |
31.87 |
| Akero Therapeutics (AKRO) |
United States |
$4.127B |
0.00 |
| Zealand Pharma (ZLDPF) |
DK |
$4.102B |
0.00 |
| Zai Lab (ZLAB) |
CN |
$4.043B |
0.00 |
| PTC Therapeutics (PTCT) |
US |
$3.889B |
6.77 |
| Ultragenyx Pharmaceutical (RARE) |
US |
$3.773B |
0.00 |
| Ascentage Pharma Group - (AAPG) |
China |
$3.733B |
0.00 |
| Merus (MRUS) |
NL |
$3.725B |
0.00 |
| Arcellx (ACLX) |
United States |
$3.701B |
0.00 |
| Avidity Biosciences (RNA) |
US |
$3.516B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.506B |
30.81 |
| Scholar Rock Holding (SRRK) |
US |
$3.417B |
0.00 |
| Viking Therapeutics (VKTX) |
US |
$3.166B |
0.00 |
| Protagonist Therapeutics (PTGX) |
US |
$3.164B |
68.07 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$3.130B |
0.00 |
| Metsera (MTSR) |
US |
$3.094B |
0.00 |
| Kymera Therapeutics (KYMR) |
US |
$2.917B |
0.00 |
| Immunovant (IMVT) |
US |
$2.897B |
0.00 |
| Alvotech (ALVO) |
Luxembourg |
$2.771B |
15.85 |
| HUTCHMED (China) (HCM) |
HK |
$2.756B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
CA |
$2.552B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
US |
$2.492B |
0.00 |
| ImmunityBio (IBRX) |
US |
$2.401B |
0.00 |
| Arrowhead Pharmaceuticals (ARWR) |
US |
$2.319B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
US |
$2.295B |
0.00 |
| Twist Bioscience (TWST) |
US |
$2.287B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
US |
$2.211B |
0.00 |
| Apogee Therapeutics (APGE) |
US |
$2.185B |
0.00 |
| Recursion Pharmaceuticals (RXRX) |
US |
$2.142B |
0.00 |
| Denali Therapeutics (DNLI) |
US |
$2.134B |
0.00 |
| Vericel (VCEL) |
US |
$2.101B |
1391.33 |
| Bavarian Nordic (BVNRY) |
DK |
$2.091B |
11.05 |
| Agios Pharmaceuticals (AGIO) |
United States |
$2.089B |
0.00 |
| CG Oncology (CGON) |
US |
$2.050B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
GB |
$2.034B |
0.00 |
| Beam Therapeutics (BEAM) |
US |
$2.012B |
0.00 |
| NovoCure (NVCR) |
JE |
$1.974B |
0.00 |
| IDEAYA Biosciences (IDYA) |
US |
$1.936B |
0.00 |
| Disc Medicine (IRON) |
US |
$1.896B |
0.00 |
| Belite Bio (BLTE) |
US |
$1.893B |
0.00 |
| Amicus Therapeutics (FOLD) |
US |
$1.878B |
203.33 |
| Harmony Biosciences Holdings (HRMY) |
US |
$1.847B |
12.27 |
| Certara (CERT) |
US |
$1.838B |
34.33 |
| Adaptive Biotechnologies (ADPT) |
United States |
$1.793B |
0.00 |
| Sarepta Therapeutics (SRPT) |
US |
$1.793B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
US |
$1.729B |
0.00 |
| GRAIL (GRAL) |
US |
$1.681B |
0.00 |
| Immunocore Holdings (IMCR) |
GB |
$1.659B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
US |
$1.647B |
0.00 |
| Vera Therapeutics (VERA) |
US |
$1.531B |
0.00 |
| Biohaven (BHVN) |
US |
$1.494B |
0.00 |
| 89BIO (ETNB) |
US |
$1.483B |
0.00 |
| Celldex Therapeutics (CLDX) |
US |
$1.460B |
0.00 |
| Janux Therapeutics (JANX) |
US |
$1.447B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
US |
$1.414B |
14.57 |
| Edgewise Therapeutics (EWTX) |
US |
$1.371B |
0.00 |
| Mesoblast (MESO) |
AU |
$1.365B |
0.00 |
| Travere Therapeutics (TVTX) |
US |
$1.333B |
0.00 |
| Viridian Therapeutics (VRDN) |
US |
$1.279B |
0.00 |
| Dynavax Technologies (DVAX) |
US |
$1.233B |
73.36 |
| CureVac (CVAC) |
DE |
$1.223B |
5.92 |
| Structure Therapeutics (GPCR) |
US |
$1.168B |
0.00 |
| AbCellera Biologics (ABCL) |
Canada |
$1.134B |
0.00 |
| Intellia Therapeutics (NTLA) |
US |
$1.112B |
0.00 |
| Novavax (NVAX) |
US |
$1.101B |
2.57 |
| MannKind (MNKD) |
US |
$1.094B |
22.50 |
| WAVE Life Sciences (WVE) |
SG |
$1.081B |
0.00 |
| Pacira BioSciences (PCRX) |
US |
$1.075B |
10.23 |
| Liquidia Technologies (LQDA) |
US |
$1.042B |
0.00 |
| Niagen Bioscience (NAGE) |
US |
$1.001B |
141.22 |
| Cidara Therapeutics (CDTX) |
US |
$0.984B |
0.00 |
| BGM Group (BGM) |
CN |
$0.975B |
0.00 |
| Pharvaris (PHVS) |
NL |
$0.973B |
0.00 |
| NeoGenomics (NEO) |
US |
$0.972B |
0.00 |
| Nurix Therapeutics (NRIX) |
US |
$0.970B |
0.00 |
| Praxis Precision Medicines (PRAX) |
US |
$0.963B |
0.00 |
| Spyre Therapeutics (SYRE) |
US |
$0.950B |
0.00 |
| Mineralys Therapeutics (MLYS) |
US |
$0.948B |
0.00 |
| MiMedx (MDXG) |
US |
$0.936B |
22.64 |
| Sionna Therapeutics (SION) |
US |
$0.935B |
0.00 |
| Anavex Life Sciences (AVXL) |
US |
$0.921B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
US |
$0.920B |
0.00 |
| LENZ Therapeutics (LENZ) |
US |
$0.916B |
0.00 |
| Geron (GERN) |
US |
$0.911B |
0.00 |
| Zymeworks (ZYME) |
US |
$0.909B |
0.00 |
| Arcus Biosciences (RCUS) |
US |
$0.897B |
0.00 |
| Cogent Biosciences (COGT) |
US |
$0.863B |
0.00 |
| Oculis Holding AG (OCS) |
CH |
$0.830B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.808B |
0.00 |
| UniQure (QURE) |
NL |
$0.790B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.788B |
52.82 |
| GH Research (GHRS) |
IE |
$0.776B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
US |
$0.774B |
0.00 |
| Pharming Group (PHGUF) |
NL |
$0.772B |
0.00 |
| Immunome (IMNM) |
US |
$0.769B |
0.00 |
| Gyre Therapeutics (GYRE) |
US |
$0.762B |
203.25 |
| Vir Biotechnology (VIR) |
US |
$0.748B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
US |
$0.745B |
0.00 |
| Replimune (REPL) |
US |
$0.725B |
0.00 |
| Pharming Group (PHAR) |
NL |
$0.720B |
0.00 |
| Sana Biotechnology (SANA) |
US |
$0.719B |
0.00 |
| Nuvation Bio (NUVB) |
US |
$0.711B |
0.00 |
| ArriVent BioPharma (AVBP) |
US |
$0.711B |
0.00 |
| Trevi Therapeutics (TRVI) |
US |
$0.698B |
0.00 |
| AnaptysBio (ANAB) |
US |
$0.698B |
0.00 |
| Immatics (IMTX) |
DE |
$0.694B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
US |
$0.689B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
US |
$0.669B |
0.00 |
| Sinovac Biotech (SVA) |
CN |
$0.645B |
0.00 |
| Autolus Therapeutics (AUTL) |
GB |
$0.631B |
0.00 |
| Stoke Therapeutics (STOK) |
US |
$0.627B |
14.53 |
| Urogen Pharma (URGN) |
US |
$0.626B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
US |
$0.623B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.621B |
0.00 |
| Tango Therapeutics (TNGX) |
US |
$0.618B |
0.00 |
| Dianthus Therapeutics (DNTH) |
US |
$0.606B |
0.00 |
| Jyong Biotech (MENS) |
TW |
$0.604B |
0.00 |
| MeiraGTx Holdings (MGTX) |
US |
$0.604B |
0.00 |
| Upstream Bio (UPB) |
US |
$0.602B |
0.00 |
| Castle Biosciences (CSTL) |
US |
$0.586B |
39.80 |
| Iovance Biotherapeutics (IOVA) |
US |
$0.584B |
0.00 |
| Arvinas (ARVN) |
US |
$0.580B |
0.00 |
| Sage Therapeutics (SAGE) |
US |
$0.576B |
0.00 |
| Keros Therapeutics (KROS) |
US |
$0.546B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
US |
$0.542B |
0.00 |
| Tyra Biosciences (TYRA) |
US |
$0.531B |
0.00 |
| Opthea (OPT) |
AU |
$0.525B |
0.00 |
| Celcuity (CELC) |
US |
$0.522B |
0.00 |
| Myriad Genetics (MYGN) |
US |
$0.516B |
0.00 |
| Bicycle Therapeutics (BCYC) |
GB |
$0.515B |
0.00 |
| Kura Oncology (KURA) |
US |
$0.507B |
0.00 |
| Septerna (SEPN) |
US |
$0.507B |
0.00 |
| Abivax SA (ABVX) |
France |
$0.505B |
0.00 |
| Maze Therapeutics (MAZE) |
US |
$0.504B |
0.00 |
| Bicara Therapeutics (BCAX) |
US |
$0.492B |
0.00 |
| Precigen (PGEN) |
US |
$0.478B |
0.00 |
| Cytek Biosciences (CTKB) |
US |
$0.476B |
0.00 |
| ATyr Pharma (ATYR) |
US |
$0.473B |
0.00 |
| Fortrea Holdings (FTRE) |
US |
$0.472B |
13.05 |
| Cullinan Therapeutics (CGEM) |
US |
$0.461B |
0.00 |
| Mereo BioPharma Group - (MREO) |
GB |
$0.456B |
0.00 |
| Kamada (KMDA) |
IL |
$0.453B |
27.17 |
| Oxford BioMedica (OXBDF) |
GB |
$0.448B |
0.00 |
| Rapport Therapeutics (RAPP) |
US |
$0.439B |
0.00 |
| REGENXBIO (RGNX) |
US |
$0.438B |
0.00 |
| PureTech Health (PRTC) |
US |
$0.433B |
0.00 |
| Zenas BioPharma (ZBIO) |
US |
$0.420B |
0.00 |
| Prime Medicine (PRME) |
US |
$0.418B |
0.00 |
| MBX Biosciences (MBX) |
US |
$0.417B |
0.00 |
| Rezolute (RZLT) |
US |
$0.412B |
0.00 |
| Erasca (ERAS) |
US |
$0.408B |
0.00 |
| Tectonic Therapeutic (TECX) |
US |
$0.398B |
0.00 |
| Solid Biosciences (SLDB) |
US |
$0.390B |
0.00 |
| ITeos Therapeutics (ITOS) |
US |
$0.390B |
0.00 |
| Eton Pharmaceuticals (ETON) |
US |
$0.388B |
0.00 |
| Compass Therapeutics (CMPX) |
US |
$0.384B |
0.00 |
| Vigil Neuroscience (VIGL) |
US |
$0.381B |
0.00 |
| Emergent Biosolutions (EBS) |
US |
$0.379B |
0.00 |
| Citius Oncology (CTOR) |
US |
$0.379B |
0.00 |
| Terns Pharmaceuticals (TERN) |
US |
$0.377B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
US |
$0.374B |
0.00 |
| Fulcrum Therapeutics (FULC) |
US |
$0.374B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
US |
$0.362B |
0.00 |
| Humacyte (HUMA) |
US |
$0.354B |
0.00 |
| Absci (ABSI) |
United States |
$0.353B |
0.00 |
| Amarin (AMRN) |
IE |
$0.346B |
0.00 |
| Prothena (PRTA) |
IE |
$0.346B |
0.00 |
| Benitec Biopharma (BNTC) |
US |
$0.346B |
0.00 |
| Aura Biosciences (AURA) |
US |
$0.330B |
0.00 |
| Astria Therapeutics (ATXS) |
US |
$0.328B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
US |
$0.326B |
0.00 |
| XOMA Royalty (XOMA) |
US |
$0.323B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
US |
$0.320B |
0.00 |
| DBV Technologies S.A (DBVT) |
FR |
$0.318B |
0.00 |
| Annexon (ANNX) |
US |
$0.317B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
US |
$0.313B |
0.00 |
| Crescent Biopharma (CBIO) |
US |
$0.311B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
US |
$0.310B |
0.00 |
| Aardvark Therapeutics (AARD) |
United States |
$0.302B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.301B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
US |
$0.300B |
60.88 |
| Lifecore Biomedical (LFCR) |
US |
$0.298B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
US |
$0.293B |
0.00 |
| Cartesian Therapeutics (RNAC) |
US |
$0.291B |
0.00 |
| Inventiva S.A (IVA) |
FR |
$0.288B |
0.00 |
| Neurogene (NGNE) |
US |
$0.287B |
0.00 |
| Foghorn Therapeutics (FHTX) |
US |
$0.286B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
CN |
$0.285B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$0.283B |
0.00 |
| Gossamer Bio (GOSS) |
US |
$0.282B |
0.00 |
| Ocugen (OCGN) |
US |
$0.279B |
0.00 |
| Alpha Teknova (TKNO) |
US |
$0.278B |
0.00 |
| Entrada Therapeutics (TRDA) |
US |
$0.274B |
8.93 |
| Corvus Pharmaceuticals (CRVS) |
US |
$0.269B |
0.00 |
| Palvella Therapeutics (PVLA) |
US |
$0.267B |
0.00 |
| Verastem (VSTM) |
US |
$0.264B |
0.00 |
| Allogene Therapeutics (ALLO) |
United States |
$0.260B |
0.00 |
| Candel Therapeutics (CADL) |
US |
$0.256B |
0.00 |
| Sagimet Biosciences (SGMT) |
US |
$0.253B |
0.00 |
| Prima BioMed (IMMP) |
AU |
$0.251B |
0.00 |
| Third Harmonic Bio (THRD) |
US |
$0.245B |
0.00 |
| Cardiff Oncology (CRDF) |
US |
$0.243B |
0.00 |
| Adherex Technologies (FENC) |
US |
$0.243B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.239B |
0.00 |
| MaxCyte (MXCT) |
US |
$0.238B |
0.00 |
| Inhibrx Biosciences (INBX) |
US |
$0.236B |
0.14 |
| Codexis (CDXS) |
US |
$0.229B |
0.00 |
| ProQR Therapeutics (PRQR) |
NL |
$0.229B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
US |
$0.228B |
0.00 |
| Monopar Therapeutics (MNPR) |
US |
$0.222B |
0.00 |
| SELLAS Life Sciences (SLS) |
US |
$0.217B |
0.00 |
| Adocia (ADOCY) |
France |
$0.216B |
0.00 |
| Editas Medicine (EDIT) |
US |
$0.215B |
0.00 |
| Design Therapeutics (DSGN) |
US |
$0.214B |
0.00 |
| Tvardi Therapeutics (TVRD) |
US |
$0.210B |
0.00 |
| ScPharmaceuticals (SCPH) |
US |
$0.210B |
0.00 |
| Kodiak Sciences (KOD) |
US |
$0.208B |
0.00 |
| AC Immune (ACIU) |
Switzerland |
$0.208B |
0.00 |
| CARGO Therapeutics (CRGX) |
US |
$0.206B |
0.00 |
| CytomX Therapeutics (CTMX) |
US |
$0.202B |
5.21 |
| Bright Minds Biosciences (DRUG) |
US |
$0.200B |
0.00 |
| BioStem Technologies (BSEM) |
|
$0.200B |
8.12 |
| Y-mAbs Therapeutics (YMAB) |
US |
$0.195B |
0.00 |
| EnGene Holdings (ENGN) |
CA |
$0.194B |
0.00 |
| Eupraxia Pharmaceuticals (EPRX) |
CA |
$0.194B |
0.00 |
| GENFIT S.A (GNFT) |
FR |
$0.193B |
0.00 |
| Alumis (ALMS) |
United States |
$0.185B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
US |
$0.184B |
0.00 |
| Instil Bio (TIL) |
US |
$0.180B |
0.00 |
| Puma Biotechnology (PBYI) |
US |
$0.178B |
4.65 |
| Voyager Therapeutics (VYGR) |
US |
$0.177B |
0.00 |
| Tiziana Life Sciences (TLSA) |
GB |
$0.176B |
0.00 |
| I-Mab (IMAB) |
US |
$0.176B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
US |
$0.169B |
0.00 |
| Innate Pharma S.A (IPHA) |
FR |
$0.168B |
0.00 |
| Alpha Cognition (ACOG) |
Canada |
$0.168B |
0.00 |
| Agenus (AGEN) |
United States |
$0.166B |
0.00 |
| Spero Therapeutics (SPRO) |
US |
$0.163B |
0.00 |
| Anika Therapeutics (ANIK) |
US |
$0.161B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
US |
$0.161B |
0.00 |
| Nuvectis Pharma (NVCT) |
US |
$0.158B |
0.00 |
| Compugen (CGEN) |
IL |
$0.157B |
0.00 |
| BioAge Labs (BIOA) |
US |
$0.153B |
0.00 |
| Molecular Partners AG (MOLN) |
CH |
$0.152B |
0.00 |
| Alector (ALEC) |
United States |
$0.151B |
0.00 |
| Ventyx Biosciences (VTYX) |
US |
$0.148B |
0.00 |
| Theratechnologies (THTX) |
CA |
$0.147B |
0.00 |
| Black Diamond Therapeutics (BDTX) |
US |
$0.147B |
43.00 |
| Cuprina Holdings (Cayman) (CUPR) |
SG |
$0.145B |
0.00 |
| Skye Bioscience (SKYE) |
US |
$0.143B |
0.00 |
| 23andMe Holding (MEHCQ) |
US |
$0.135B |
0.00 |
| Greenwich LifeSciences (GLSI) |
US |
$0.134B |
0.00 |
| Seer (SEER) |
US |
$0.134B |
0.00 |
| Rapt Therapeutics (RAPT) |
US |
$0.133B |
0.00 |
| Neumora Therapeutics (NMRA) |
US |
$0.133B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
United States |
$0.129B |
0.00 |
| Fate Therapeutics, Inc. (FATE) |
US |
$0.128B |
0.00 |
| Caribou Biosciences, Inc. (CRBU) |
US |
$0.127B |
0.00 |
| Elicio Therapeutics, Inc. (ELTX) |
US |
$0.127B |
0.00 |
| Nkarta, Inc. (NKTX) |
US |
$0.124B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.124B |
0.00 |
| Sangamo Therapeutics, Inc. (SGMO) |
US |
$0.123B |
0.00 |
| Kyverna Therapeutics, Inc. (KYTX) |
US |
$0.121B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.113B |
0.00 |
| Genelux Corporation (GNLX) |
US |
$0.112B |
0.00 |
| Orchestra BioMed Holdings, Inc. (OBIO) |
US |
$0.111B |
0.00 |
| TuHURA Biosciences, Inc. (HURA) |
US |
$0.108B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.105B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.104B |
0.00 |
| Milestone Pharmaceuticals Inc. (MIST) |
CA |
$0.104B |
0.00 |
| Seres Therapeutics, Inc. (MCRB) |
US |
$0.104B |
0.00 |
| Nautilus Biotechnology, Inc. (NAUT) |
US |
$0.103B |
0.00 |
| HilleVax, Inc. (HLVX) |
US |
$0.103B |
0.00 |
| Jasper Therapeutics, Inc. (JSPR) |
US |
$0.102B |
0.00 |
| Contineum Therapeutics, Inc. (CTNM) |
US |
$0.100B |
0.00 |
| Coya Therapeutics, Inc. (COYA) |
US |
$0.100B |
0.00 |
| Tenaya Therapeutics, Inc. (TNYA) |
US |
$0.100B |
0.00 |
| IO Biotech, Inc. (IOBT) |
DK |
$0.098B |
0.00 |
| Prenetics Global Limited (PRE) |
HK |
$0.098B |
0.00 |
| XBiotech Inc. (XBIT) |
US |
$0.097B |
0.00 |
| OKYO Pharma Limited Sponsored ADR (OKYO) |
|
$0.094B |
0.00 |
| Coherus Oncology, Inc. (CHRS) |
US |
$0.094B |
0.00 |
| Whitehawk Therapeutics, Inc. (WHWK) |
US |
$0.094B |
0.00 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) |
US |
$0.091B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.090B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.090B |
0.00 |
| Invivyd, Inc. (IVVD) |
US |
$0.088B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.088B |
0.00 |
| Adagene Inc. Sponsored ADR (ADAG) |
China |
$0.087B |
0.00 |
| Oncolytics Biotech Inc. (ONCY) |
CA |
$0.087B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.087B |
0.00 |
| Elutia Inc. (ELUT) |
US |
$0.086B |
0.00 |
| Entera Bio Ltd. (ENTX) |
IL |
$0.086B |
0.00 |
| TScan Therapeutics, Inc. (TCRX) |
US |
$0.085B |
0.00 |
| eXoZymes Inc. (EXOZ) |
US |
$0.083B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.083B |
0.00 |
| IGM Biosciences, Inc. (IGMS) |
US |
$0.081B |
0.00 |
| TELA Bio, Inc. (TELA) |
US |
$0.081B |
0.00 |
| Pliant Therapeutics, Inc. (PLRX) |
US |
$0.077B |
0.00 |
| Zura Bio Limited (ZURA) |
US |
$0.077B |
0.00 |
| Quince Therapeutics, Inc. (QNCX) |
US |
$0.073B |
0.00 |
| Immix Biopharma, Inc. (IMMX) |
US |
$0.071B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
United States |
$0.070B |
0.00 |
| Immunic, Inc. (IMUX) |
US |
$0.070B |
0.00 |
| Genenta Science S.p.A. Unsponsored ADR (GNTA) |
IT |
$0.070B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.069B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
United States |
$0.068B |
0.00 |
| Adaptimmune Therapeutics PLC (ADAP) |
United Kingdom |
$0.066B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.065B |
0.00 |
| Sutro Biopharma, Inc. (STRO) |
US |
$0.064B |
0.00 |
| Ikena Oncology, Inc. (IKNA) |
US |
$0.064B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.064B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.063B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.062B |
0.00 |
| Repare Therapeutics Inc. (RPTX) |
CA |
$0.062B |
0.00 |
| MediciNova, Inc. (MNOV) |
US |
$0.061B |
0.00 |
| PDS Biotechnology Corporation (PDSB) |
US |
$0.061B |
0.00 |
| Oncobiologics, Inc. (OTLK) |
US |
$0.060B |
0.00 |
| INmune Bio, Inc. (INMB) |
US |
$0.060B |
0.00 |
| Opus Genetics, Inc. (IRD) |
US |
$0.060B |
0.00 |
| VistaGen Therapeutics, Inc. (VTGN) |
US |
$0.058B |
0.00 |
| Earth Science Tech, Inc. (ETST) |
US |
$0.057B |
0.00 |
| Senti Biosciences, Inc. (SNTI) |
US |
$0.057B |
0.00 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.056B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.055B |
0.00 |
| InflaRx N.V. (IFRX) |
DE |
$0.054B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
United States |
$0.053B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.052B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.050B |
0.00 |
| Adicet Bio, Inc. (ACET) |
United States |
$0.050B |
0.00 |
| RenovoRx, Inc. (RNXT) |
US |
$0.050B |
0.00 |
| Renovaro Inc. (RENB) |
US |
$0.050B |
0.00 |
| Quantum Biopharma Ltd. (QNTM) |
CA |
$0.050B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.049B |
0.00 |
| Inovio Pharmaceuticals, Inc. (INO) |
US |
$0.049B |
0.00 |
| vTv Therapeutics Inc. (VTVT) |
US |
$0.048B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.048B |
0.00 |
| Werewolf Therapeutics, Inc. (HOWL) |
US |
$0.048B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
United States |
$0.048B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
United States |
$0.048B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.047B |
0.00 |
| Kalaris Therapeutics Inc. (KLRS) |
US |
$0.047B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.046B |
0.00 |
| Medicus Pharma Ltd (MDCX) |
US |
$0.046B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.045B |
0.00 |
| Pluri Inc. (PLUR) |
IL |
$0.045B |
0.00 |
| Scilex Holding Company (SCLX) |
US |
$0.044B |
0.00 |
| Grace Therapeutics, Inc. (GRCE) |
CA |
$0.043B |
0.00 |
| Exicure, Inc. (XCUR) |
US |
$0.043B |
0.00 |
| PepGen, Inc. (PEPG) |
US |
$0.040B |
0.00 |
| Shattuck Labs, Inc. (STTK) |
US |
$0.040B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.039B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
United Kingdom |
$0.038B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.037B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.037B |
0.00 |
| Xilio Therapeutics, Inc. (XLO) |
US |
$0.036B |
0.00 |
| Mersana Therapeutics, Inc. (MRSN) |
US |
$0.036B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.035B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.035B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.035B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.033B |
0.00 |
| Rein Therapeutics Inc. (RNTX) |
US |
$0.033B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.033B |
0.00 |
| OnKure Therapeutics, Inc. (OKUR) |
US |
$0.032B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.032B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.032B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.031B |
0.00 |
| Radiopharm Theranostics Limited - Sponsored ADR (RADX) |
AU |
$0.031B |
0.00 |
| Rani Therapeutics Holdings, Inc. (RANI) |
US |
$0.031B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.029B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.029B |
0.00 |
| Passage Bio, Inc. (PASG) |
US |
$0.029B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.028B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.026B |
0.00 |
| NeuroSense Therapeutics Ltd. (NRSN) |
IL |
$0.026B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.026B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.025B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
United States |
$0.025B |
0.00 |
| Tenax Therapeutics, Inc. (TENX) |
US |
$0.024B |
0.00 |
| Ovid Therapeutics (OVID) |
US |
$0.024B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.024B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.024B |
0.00 |
| FibroBiologics Inc. (FBLG) |
US |
$0.023B |
0.00 |
| Generation Bio Co. (GBIO) |
US |
$0.023B |
0.00 |
| Elevation Oncology, Inc. (ELEV) |
US |
$0.023B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.023B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.023B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.022B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.022B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.021B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.021B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.020B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.020B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.020B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.019B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.018B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.018B |
0.00 |
| Q32 Bio Inc. (QTTB) |
US |
$0.018B |
0.00 |
| Gelteq Limited (GELS) |
AU |
$0.016B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.016B |
0.00 |
| SAB Biotherapeutics, Inc. (SABS) |
US |
$0.016B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.016B |
0.00 |
| Beyond Air, Inc. (XAIR) |
US |
$0.015B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
United States |
$0.015B |
0.00 |
| HOOKIPA Pharma Inc. (HOOK) |
US |
$0.015B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
United States |
$0.015B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.015B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.014B |
0.00 |
| Promis Neurosciences (PMN) |
CA |
$0.014B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.014B |
0.00 |
| Rallybio Corporation (RLYB) |
US |
$0.014B |
0.00 |
| Synlogic, Inc. (SYBX) |
US |
$0.014B |
0.00 |
| Neuphoria Therapeutics Inc. (NEUP) |
AU |
$0.013B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.013B |
0.00 |
| MetaVia Inc. (MTVA) |
US |
$0.013B |
0.00 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) |
US |
$0.012B |
0.00 |
| iBio, Inc. (IBIO) |
US |
$0.012B |
0.00 |
| NextCure, Inc. (NXTC) |
US |
$0.012B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.012B |
0.00 |
| Synaptogenix, Inc. (TAOX) |
US |
$0.012B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.012B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.012B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.011B |
0.00 |
| Abpro Holdings Inc. (ABP) |
United States |
$0.011B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.011B |
0.00 |
| Sensei Biotherapeutics, Inc. (SNSE) |
US |
$0.011B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.011B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.011B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
United States |
$0.011B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.011B |
0.00 |
| X4 Pharmaceuticals, Inc. (XFOR) |
US |
$0.011B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.011B |
0.00 |
| COSCIENS Biopharma Inc. (CSCI) |
CA |
$0.011B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.010B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.010B |
0.00 |
| Jade Biosciences, Inc. (JBIO) |
US |
$0.009B |
0.00 |
| LakeShore Biopharma Co., Ltd. (LSB) |
CN |
$0.009B |
0.00 |
| Dogwood Therapeutics, Inc (DWTX) |
US |
$0.009B |
0.00 |
| Turnstone Biologics Corp. (TSBX) |
US |
$0.008B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.008B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.008B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.008B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.007B |
0.00 |
| GENPREX (GNPX) |
US |
$0.007B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.007B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.007B |
0.00 |
| Sunshine Biopharma, Inc. (SBFM) |
US |
$0.007B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
IL |
$0.007B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.007B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.007B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.007B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.007B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.007B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.007B |
0.00 |
| Arcadia Biosciences, Inc. (RKDA) |
US |
$0.006B |
0.00 |
| Portage Biotech Inc. (PRTG) |
|
$0.006B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.006B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
|
$0.006B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.006B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.005B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.005B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.005B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.005B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
United States |
$0.005B |
0.00 |
| UNITY Biotechnology, Inc. (UBX) |
US |
$0.005B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.005B |
0.00 |
| Tharimmune, Inc. (THAR) |
US |
$0.005B |
0.00 |
| Mainz Biomed NV (MYNZ) |
DE |
$0.005B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.005B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.005B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.004B |
0.00 |
| VivoSim Labs, Inc. (VIVS) |
US |
$0.004B |
0.00 |
| Titan Pharmaceuticals, Inc. (TTNP) |
US |
$0.004B |
0.00 |
| Soligenix Inc. (SNGX) |
US |
$0.004B |
0.00 |
| Polyrizon Ltd. (PLRZ) |
IL |
$0.004B |
0.00 |
| Virax Biolabs Group Limited (VRAX) |
GB |
$0.004B |
0.00 |
| Revelation Biosciences, Inc. (REVB) |
US |
$0.004B |
0.00 |
| Palisade Bio, Inc. (PALI) |
US |
$0.003B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
United States |
$0.003B |
0.00 |
| Windtree Therapeutics, Inc. (WINT) |
US |
$0.003B |
0.00 |
| Purple Biotech Ltd. Sponsored ADR (PPBT) |
IL |
$0.003B |
0.00 |
| ZyVersa Therapeutics, Inc. (ZVSA) |
US |
$0.003B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.003B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.003B |
0.00 |
| Psyence Biomedical Ltd. (PBM) |
CA |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Silo Pharma, Inc. (SILO) |
US |
$0.003B |
0.00 |
| Onconetix, Inc. (ONCO) |
US |
$0.002B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
United States |
$0.002B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.002B |
0.00 |
| Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) |
IL |
$0.002B |
0.00 |
| Atrinsic Inc. (PTIX) |
US |
$0.002B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| NuCana PLC Sponsored ADR (NCNA) |
GB |
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
United States |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| PDL BioPharma, Inc. (PDLI) |
US |
$0.000B |
0.00 |
| Pulmatrix, Inc. (PULM) |
US |
$0.000B |
0.00 |
| TFF Pharmaceuticals, Inc. (TFFP) |
US |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
CH |
$0.000B |
0.00 |
